Witnessing the stock’s movement on the chart, on Wednesday, Edgewise Therapeutics Inc (NASDAQ: EWTX) had a quiet start as it plunged -2.37% to $22.26, before settling in for the price of $22.80 at the close. Taking a more long-term approach, EWTX posted a 52-week range of $14.90-$38.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was -49.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -31.66%. This publicly-traded company’s shares outstanding now amounts to $94.84 million, simultaneously with a float of $67.23 million. The organization now has a market capitalization sitting at $2.12 billion. At the time of writing, stock’s 50-day Moving Average stood at $26.47, while the 200-day Moving Average is $25.38.
Edgewise Therapeutics Inc (EWTX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Edgewise Therapeutics Inc’s current insider ownership accounts for 29.38%, in contrast to 78.78% institutional ownership. According to the most recent insider trade that took place on Mar 07 ’25, this organization’s Chief Scientific Officer sold 200 shares at the rate of 30.02, making the entire transaction reach 6,004 in total value, affecting insider ownership by 14,863. Preceding that transaction, on Mar 07 ’25, Company’s President and CEO sold 100 for 30.00, making the whole transaction’s value amount to 3,000. This particular insider is now the holder of 14,478 in total.
Edgewise Therapeutics Inc (EWTX) Earnings and Revenue Records
Edgewise Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -31.66% and is forecasted to reach -2.15 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -13.50% through the next 5 years, which can be compared against the -49.00% growth it accomplished over the previous five years trading on the market.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Let’s observe the current performance indicators for Edgewise Therapeutics Inc (EWTX). It’s Quick Ratio in the last reported quarter now stands at 19.93. The Stock has managed to achieve an average true range (ATR) of 1.94.
In the same vein, EWTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.45, a figure that is expected to reach -0.43 in the next quarter, and analysts are predicting that it will be -2.15 at the market close of one year from today.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
Going through the that latest performance of [Edgewise Therapeutics Inc, EWTX]. Its last 5-days volume of 1.41 million indicated improvement to the volume of 1.17 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 15.91% While, its Average True Range was 1.93.
Raw Stochastic average of Edgewise Therapeutics Inc (EWTX) in the period of the previous 100 days is set at 2.40%, which indicates a major fall in contrast to 4.77% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 46.73% that was lower than 59.87% volatility it exhibited in the past 100-days period.
